English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24281847      Online Users : 57
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34312

    標題: Efficacy of intraoperative intravenous lidocaine for postoperative analgesia following bariatric surgery: a meta-analysis of randomized controlled studies
    作者: Hung, Kuo-Chuan
    Chang, Ying-Jen
    Chen, I-Wen
    Chang, Yang-Pei
    Chiu, Sheng-Fu
    Sun, Cheuk-Kwan
    貢獻者: Chi Mei Med Ctr, Dept Anesthesiol
    Chia Nan Univ Pharm & Sci, Gen Educ Ctr
    Chia Nan Univ Pharm & Sci,Dept Recreat & Hlth Care Management
    Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol
    Chi Mei Hosp, Dept Oral & Maxillofacial Surg
    E Da Hosp, Dept Emergency Med
    I Shou Univ, Coll Med
    關鍵字: Laparoscopic bariatric surgery
    Quality of recovery
    日期: 2021
    上傳時間: 2023-11-11 11:42:43 (UTC+8)
    摘要: Background: The impact of intravenous lidocaine in adults undergoing laparoscopic bariatric sur-geries (LBS) remains unclear. Objectives: This study aimed at investigating the effect of intravenous lidocaine on postoperative opioid consumption and recovery following LBS. Setting: Meta-analysis. Methods: We searched databases including MEDLINE, Embase, Google Scholar, and the Cochrane Library for randomized controlled trials that evaluated the use of intravenous lidocaine compared to placebo only prior to May 2021. The primary outcome was 24-hour postoperative opioid consump-tion, while secondary outcomes included pain score, quality of recovery (QOR)-40 score, length of hospital stay (LOS), and postoperative nausea/vomiting (PONV). Results: Seven trials (496 participants) were included. Intraoperative intravenous lidocaine signif-icantly reduced 24-hour equivalent morphine consumption (mean difference [MD]: -11.97 mg; 95% confidence interval [CI]: -23.12 to -.83), pain score at 1 to 3 hours (MD: -.77; 95% CI: -1.5 to -.04), and LOS (MD: -8.93 hr; 95% CI: -13.41 to -4.44) without positive impact on 24-hour pain score and PONV. There was also an increase in time to first opioid requirement (MD: 20.23 min; 95% CI: 11.76-28.7) and QOR-40 score (MD: 24.38; 95% CI: 5.57-43.18). How-ever, sensitivity analysis demonstrated evidence supporting the beneficial effect of lidocaine only for time to first opioid requirement and QOR-40. The associations of intraoperative intravenous lidocaine with reductions in morphine consumption, pain score at 1 to 3 hours, and LOS after LBS were also weak. Conclusion: Intraoperative intravenous lidocaine during LBS prolonged time to first opioid require-ment and improved quality of recovery postoperatively without 24-hour pain or nausea/vomiting benefits. Due to the small number of trials, larger studies are warranted to verify our findings. (C) 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
    關聯: SURG OBES RELAT DIS, v.18, n.1, pp.135-147
    Appears in Collections:[通識教育中心] 期刊論文
    [休閒保健管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback